Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 36 studies with search of: | "Floxuridine" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer
|
||||
2 | Recruiting |
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-Esophageal Junction (GEJ) Cancers
|
||||
3 | Completed |
Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
|
||||
4 | Active, not recruiting |
Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
|
||||
5 | Completed |
Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer
|
||||
6 | Recruiting |
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
|
||||
7 | Completed |
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
|
||||
8 | Completed |
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Treating Patients With Primary Liver Cancer That Cannot Be Removed By Surgery
|
||||
9 | Active, not recruiting |
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
|
||||
10 | Completed |
A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
|
||||
11 | Recruiting |
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy and Bevacizumab in Treating Patients With Colorectal Cancer That Has Spread to the Liver
|
||||
12 | Active, not recruiting |
Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
|
||||
13 | Active, not recruiting |
Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer
|
||||
14 | Recruiting |
Intraperitoneal Floxuridine in Gastric Carcinoma
|
||||
15 | Recruiting |
Radiolabeled Monoclonal Antibody, Gemcitabine, and Hepatic Arterial Infusion of Floxuridine in Treating Patients With Metastatic Colorectal Cancer and Liver Metastases
|
||||
16 | Completed |
Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer
|
||||
17 | Active, not recruiting |
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
|
||||
18 | Active, not recruiting |
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
|
||||
19 | Recruiting |
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
|
||||
20 | Active, not recruiting |
Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer
|
Previous Page | Studies Shown (1-20) | Next Page (21-36) |